Literature DB >> 11846782

Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 1003.

Martin Månsson1, Derek W Hood, Jianjun Li, James C Richards, E Richard Moxon, Elke K H Schweda.   

Abstract

Structural analysis of the lipopolysaccharide (LPS) of nontypeable Haemophilus influenzae strain 1003 has been achieved by the application of high-field NMR techniques, ESI-MS, capillary electrophoresis coupled to ESI-MS, composition and linkage analyses on O-deacylated LPS and core oligosaccharide material. It was found that the LPS contains the common structural element of H. influenzae, l-alpha-D-Hepp-(1-->2)-[PEtn-->6]-l-alpha-D-Hepp-(1-->3)-[beta-D-Glcp-(1-->4)]-l-alpha-D-Hepp-(1-->5)-[PP Etn-->4]-alpha-Kdop-(2-->6)-Lipid A, in which the beta-D-Glcp residue is substituted by phosphocholine at O-6 and an acetyl group at O-4. A second acetyl group is located at O-3 of the distal heptose residue (HepIII). HepIII is chain elongated at O-2 by either a beta-D-Glcp residue (major), lactose or sialyllactose (minor, i.e. alpha-Neu5Ac-(2-->3)-beta-D-Galp-(1-->4)-beta-D-Glcp), where a third minor acetylation site was identified at the glucose residue. Disialylated species were also detected. In addition, a minor substitution of ester-linked glycine at HepIII and Kdo was observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846782     DOI: 10.1046/j.0014-2956.2001.02707.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Biosynthesis of cryptic lipopolysaccharide glycoforms in Haemophilus influenzae involves a mechanism similar to that required for O-antigen synthesis.

Authors:  Derek W Hood; Gaynor Randle; Andrew D Cox; Katherine Makepeace; Jianjun Li; Elke K H Schweda; James C Richards; E Richard Moxon
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

2.  Characterization of Two Novel Lipopolysaccharide Phosphoethanolamine Transferases in Pasteurella multocida and Their Role in Resistance to Cathelicidin-2.

Authors:  Marina Harper; Amy Wright; Frank St Michael; Jianjun Li; Deanna Deveson Lucas; Mark Ford; Ben Adler; Andrew D Cox; John D Boyce
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

3.  Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae.

Authors:  Kate L Fox; Jianjun Li; Elke K H Schweda; Varvara Vitiazeva; Katherine Makepeace; Michael P Jennings; E Richard Moxon; Derek W Hood
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

4.  Application of capillary electrophoresis mass spectrometry and liquid chromatography multiple-step tandem electrospray mass spectrometry to profile glycoform expression during Haemophilus influenzae pathogenesis in the chinchilla model of experimental otitis media.

Authors:  Susanna L Lundström; Jianjun Li; Martin Månsson; Marisol Figueira; Magali Leroy; Richard Goldstein; Derek W Hood; E Richard Moxon; James C Richards; Elke K H Schweda
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

5.  Biofilm growth increases phosphorylcholine content and decreases potency of nontypeable Haemophilus influenzae endotoxins.

Authors:  Shayla West-Barnette; Andrea Rockel; W Edward Swords
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

6.  The Eukaryotic Elongation Factor 1 Alpha (eEF1α) from the Parasite Leishmania infantum Is Modified with the Immunomodulatory Substituent Phosphorylcholine (PC).

Authors:  Thomas Timm; Giada Annoscia; Jochen Klein; Günter Lochnit
Journal:  Molecules       Date:  2017-11-29       Impact factor: 4.411

7.  Exploring the Impact of Ketodeoxynonulosonic Acid in Host-Pathogen Interactions Using Uptake and Surface Display by Nontypeable Haemophilus influenzae.

Authors:  Sudeshna Saha; Alison Coady; Aniruddha Sasmal; Kunio Kawanishi; Biswa Choudhury; Hai Yu; Ricardo U Sorensen; Jaime Inostroza; Ian C Schoenhofen; Xi Chen; Anja Münster-Kühnel; Chihiro Sato; Ken Kitajima; Sanjay Ram; Victor Nizet; Ajit Varki
Journal:  mBio       Date:  2021-01-19       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.